Loading causes.
23,088
Votes
$35,948
Raised
$15,777
Display pool
A new plan to make more medicines in America
The U.S. discovers many new medicines, but often cannot make them at large scale at home. This cause supports creating a national Biopharmaceutical Center of Excellence to improve drug manufacturing, train workers, and reduce shortages. Winning means Congress advances and funds the Biomanufacturing Excellence Act so a pilot center can launch.
When more of the medicine supply chain sits overseas, the U.S. has less control during emergencies and disruptions. COVID-19 exposed how hard it can be to ramp up production fast, and shortages of critical medicines can follow.
A Center of Excellence is meant to rebuild practical “how to manufacture” capacity, not just research. It could help the U.S. make advanced products like biologics, vaccines, and gene therapies more reliably, while training people to run modern manufacturing.
The biggest hurdle is sustained funding and agreement on which agencies lead and how the public-private partnership is run. Location politics and slow coordination across agencies could also delay a launch.
Choose which strategies should receive funding this cycle.
Sign in to vote on this cause.
Discussion posting
No threads yet. New durable discussions will appear here once posted.
Impact updates will appear here after the first cycle closes.
